컨텐츠 내용을 수정할 수 있습니다
Neurodevelopmental disorders begin in the developmental period, often before school age, and cause deficits in personal, social, academic, or occupational functioning. They reflect differences in brain development with strong genetic contributions, plus prenatal and perinatal factors (prematurity, prenatal alcohol or drug exposure, infection, hypoxia). Disruptive, impulse-control, and conduct disorders involve problems in the self-control of emotions and behavior that violate the rights of others or bring the person into conflict with social norms or authority.
| Disorder | Key features (DSM-5-TR) |
|---|---|
| Autism spectrum disorder (ASD) | Persistent deficits in social communication and interaction (social-emotional reciprocity, nonverbal communication, relationships) and restricted, repetitive patterns (stereotyped movements or speech such as hand flapping or echolalia, insistence on sameness, fixated interests, hyper- or hyporeactivity to sensory input). Severity levels 1–3 by support needed. More common in males. Large population studies have found no link between vaccines, including MMR, and autism |
| Attention-deficit/hyperactivity disorder (ADHD) | Inattention and/or hyperactivity-impulsivity: 6 or more symptoms in a domain (5 or more for age 17 and older) for at least 6 months, several present before age 12, in 2 or more settings. Presentations: predominantly inattentive, predominantly hyperactive-impulsive, combined. Linked to dopamine and norepinephrine dysregulation in frontostriatal circuits; highly heritable |
| Intellectual developmental disorder (intellectual disability) | Deficits in intellectual functioning (typically IQ about 70 or below, about 2 standard deviations below the mean) and in adaptive functioning (conceptual, social, practical), beginning in the developmental period. Severity (mild to profound) is based on adaptive functioning, not IQ alone. Causes include Down syndrome, fragile X syndrome, fetal alcohol spectrum disorder, and phenylketonuria |
| Tic disorders | Sudden, rapid, recurrent, nonrhythmic movements or sounds. Tourette disorder: multiple motor tics and at least one vocal tic, present more than 1 year, onset before 18. Tics wax and wane, worsen with stress and fatigue, and can be suppressed briefly with rising inner tension. Coprolalia occurs in a minority |
| Specific learning disorder, communication disorders, developmental coordination disorder | Reading (dyslexia), writing, or math difficulties; speech and language problems; motor coordination problems |
| Disorder | Key features |
|---|---|
| Oppositional defiant disorder (ODD) | At least 6 months of angry/irritable mood, argumentative/defiant behavior toward authority figures, or vindictiveness — at least 4 symptoms, shown with at least one person who is not a sibling |
| Conduct disorder (CD) | Repetitive pattern violating others' basic rights or major social rules: aggression to people or animals, destruction of property, deceitfulness or theft, serious rule violations (e.g., truancy, running away); at least 3 of 15 criteria in 12 months. Childhood-onset (before age 10) type has worse prognosis; specifier "with limited prosocial emotions" (lack of remorse or empathy). May progress to antisocial personality disorder in adulthood |
| Intermittent explosive disorder | Recurrent impulsive aggressive outbursts out of proportion to provocation; age at least 6 |
| Kleptomania | Recurrent failure to resist impulses to steal objects not needed for personal use or their monetary value; rising tension before, and pleasure, gratification, or relief during the act. It is an impulse-control disorder, not a sexual disorder |
| Pyromania | Deliberate, repeated fire setting with tension before and fascination and relief afterward |
Disruptive mood dysregulation disorder (DMDD) is classified with depressive disorders but is often assessed alongside these conditions: chronic, severe irritability with frequent temper outbursts (3 or more times a week) and persistently irritable mood between them, for at least 12 months; onset before age 10; diagnosed between ages 6 and 18.
| Tool | Use |
|---|---|
| M-CHAT-R/F | ASD screening at 18 and 24 months (AAP recommendation) along with general developmental surveillance |
| ADOS-2 and developmental evaluation | ASD diagnosis by specialists |
| Vanderbilt or Conners rating scales | ADHD — parent and teacher reports |
| Standardized IQ and adaptive behavior tests | Intellectual developmental disorder |
| Hearing and vision tests | Exclude sensory causes of language or attention problems |
| Genetic testing (chromosomal microarray, fragile X) | ASD or intellectual developmental disorder |
| Lead level, thyroid tests when indicated | Contributing medical causes |
| Baseline cardiac history, heart rate, blood pressure (ECG if cardiac risk) | Before stimulant therapy |
ADHD (AAP 2019 guideline)
| Drug class | Examples | Safety points |
|---|---|---|
| CNS stimulants (first-line) | methylphenidate, amphetamine salts, lisdexamfetamine | Decreased appetite and insomnia (most common), weight loss and growth slowing (plot height and weight), increased heart rate and blood pressure, headache, abdominal pain, irritability, may unmask tics, rarely psychosis or mania. Boxed warning for abuse, misuse, and addiction (updated 2023) — store securely, count doses, do not share. Contraindicated with MAOIs (within 14 days). Peripheral vasculopathy including Raynaud phenomenon (report cold, color-changing fingers). Screen for cardiac disease |
| Selective norepinephrine reuptake inhibitors | atomoxetine, viloxazine | Boxed warning: suicidal thinking in children and adolescents; atomoxetine — rare liver injury, raised heart rate and BP, contraindicated with MAOIs and in narrow-angle glaucoma; takes weeks to work |
| Alpha-2 agonists | guanfacine ER, clonidine ER | Sedation, hypotension, bradycardia; taper — abrupt stopping causes rebound hypertension; useful with tics or sleep problems |
Tic disorders — education and reassurance; Comprehensive Behavioral Intervention for Tics (CBIT) is first-line when treatment is needed; alpha-2 agonists or antipsychotics (aripiprazole) for severe tics
Intellectual developmental disorder — early intervention, special education, treatment of associated conditions, community supports
ODD and CD — parent management training, CBT, problem-solving skills training, multisystemic therapy (home, school, community); treat co-occurring ADHD. Medication is not first-line; antipsychotics or mood stabilizers only for severe aggression, with metabolic monitoring
DMDD — parent training, CBT; stimulants if ADHD co-occurs; SSRIs or antipsychotics in selected cases
Kleptomania, pyromania, IED — CBT (cue awareness, covert sensitization, relapse prevention); SSRIs or naltrexone in selected cases
Listed in priority order.
| Complication | What to watch for |
|---|---|
| Violence toward others | Threats, weapons, cruelty to animals, fire setting |
| Self-injury | Head banging, biting, cutting |
| Suicide risk | Depression in ADHD, ASD, or DMDD; atomoxetine or viloxazine therapy |
| Stimulant adverse effects | Chest pain, syncope, hypertension, growth failure, psychosis |
| Elopement and drowning | Children with ASD who wander |
| Substance use and legal problems | Adolescents with CD or untreated ADHD |
| Abuse and neglect | Children with disabilities are at higher risk |
| Metabolic syndrome | Antipsychotic therapy |
다음 이론을 계속 학습하려면 로그인하세요.
로그인하고 계속 학습필기노트, 하이라이터, 메모는 잘 쓰고 있어?
내보내줘운영진이 검토할게요!
마이페이지에서 차단한 회원을 관리할 수 있어요.